Short-Acting Insulin Market Size, Share & Trends Analysis Report By Drug (Novolog, Humalog, Humulin) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:

Market Segmentation

  1. Short-Acting Insulin Market, By Drug 2022-2034 (USD MILLION/ Units)
    1. Novolog
    2. Humalog
    3. Humulin
  2. Regional Short-Acting Insulin Market
    1. North America
      1. North America Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. U.S.
        1. Novolog
        2. Humalog
        3. Humulin
      3. Canada
        1. Novolog
        2. Humalog
        3. Humulin
    2. Europe
      1. Europe Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. U.K.
        1. Novolog
        2. Humalog
        3. Humulin
      3. Germany
        1. Novolog
        2. Humalog
        3. Humulin
      4. France
        1. Novolog
        2. Humalog
        3. Humulin
      5. Spain
        1. Novolog
        2. Humalog
        3. Humulin
      6. Italy
        1. Novolog
        2. Humalog
        3. Humulin
      7. Russia
        1. Novolog
        2. Humalog
        3. Humulin
      8. Nordic
        1. Novolog
        2. Humalog
        3. Humulin
      9. Benelux
        1. Novolog
        2. Humalog
        3. Humulin
      10. Rest of Europe
        1. Novolog
        2. Humalog
        3. Humulin
    3. APAC
      1. APAC Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. China
        1. Novolog
        2. Humalog
        3. Humulin
      3. Korea
        1. Novolog
        2. Humalog
        3. Humulin
      4. Japan
        1. Novolog
        2. Humalog
        3. Humulin
      5. India
        1. Novolog
        2. Humalog
        3. Humulin
      6. Australia
        1. Novolog
        2. Humalog
        3. Humulin
      7. Taiwan
        1. Novolog
        2. Humalog
        3. Humulin
      8. South East Asia
        1. Novolog
        2. Humalog
        3. Humulin
      9. Rest of Asia-Pacific
        1. Novolog
        2. Humalog
        3. Humulin
    4. Middle East and Africa
      1. Middle East and Africa Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. UAE
        1. Novolog
        2. Humalog
        3. Humulin
      3. Turkey
        1. Novolog
        2. Humalog
        3. Humulin
      4. Saudi Arabia
        1. Novolog
        2. Humalog
        3. Humulin
      5. South Africa
        1. Novolog
        2. Humalog
        3. Humulin
      6. Egypt
        1. Novolog
        2. Humalog
        3. Humulin
      7. Nigeria
        1. Novolog
        2. Humalog
        3. Humulin
      8. Rest of MEA
        1. Novolog
        2. Humalog
        3. Humulin
    5. LATAM
      1. LATAM Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. Brazil
        1. Novolog
        2. Humalog
        3. Humulin
      3. Mexico
        1. Novolog
        2. Humalog
        3. Humulin
      4. Argentina
        1. Novolog
        2. Humalog
        3. Humulin
      5. Chile
        1. Novolog
        2. Humalog
        3. Humulin
      6. Colombia
        1. Novolog
        2. Humalog
        3. Humulin
      7. Rest of LATAM
        1. Novolog
        2. Humalog
        3. Humulin

We are featured on: